Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN) [Phase 3]
Phase 3 trial comparing bendamustine alone to bendamustine plus obinutuzumab in rituximab-refractory indolent non-Hodgkin's lymphoma complet…
-
CLINICAL_TRIALS trial_result · 2016-11-11Clinical Trial Update: Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma [Phase 2]
Phase 2 trial of BEAM chemotherapy regimen followed by autologous stem cell transplantation for lymphoma is completed; results were posted i…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating Rituximab (MabThera/Rituxan) in patients with non-bulky follicular non-Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 trial evaluating GDC-0980 in patients with refractory solid tumors or Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma [Phase 1]
A completed Phase 1 trial evaluating the safety and tolerability of GDC-0349 in patients with locally advanced or metastatic solid tumors or…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma [Phase 1]
This Phase 1 trial evaluated escalating doses of DCDT2980S, both alone and in combination with rituximab, in adults with relapsed or refract…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable [Phase 1]
Phase 1 study of GDC-0941 (pictilisib) in patients with locally advanced or metastatic solid tumors or non-Hodgkin lymphoma; the trial has c…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Effectiveness, Safety & Nurse Management Study of MabThera SC in Patients With Non-Hodgkin's Lymphoma: Real-Life Setting
This clinical trial update reports on the real-world effectiveness and safety of MabThera SC (rituximab) in patients with Non-Hodgkin's Lymp…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study Evaluating GDC-0980 Administered Once Weekly in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating GDC-0980 administered once weekly in patients with refractory solid tumors or Non-Hodgkin's lymphoma has…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Analysis of the Risk Factors for the Neutropenic Fever in the High Risk NHL Patients for Developing Febrile Neutropenia Who Received 3-weekly CHOP-like Chemotherapy With Primary G-CSF Prophylaxis; Prospective Multicenter Observation Study
A completed prospective multicenter study in high-risk Non-Hodgkin's Lymphoma patients treated with 3-weekly CHOP-like chemotherapy and prim…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation [NA]
A terminated study compared lymphocyte reconstitution after pegfilgrastim versus filgrastim following peripheral stem cell transplantation i…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma [Phase 1, Phase 2]
Phase 1/2 study evaluating vorinostat with rituximab and chemotherapy for newly diagnosed diffuse large B-cell lymphoma across stages II-IV.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma [Phase 1, Phase 2]
This clinical trial update summarizes Phase 1/2 results for intravenous AMD3100 (plerixafor) used to collect autologous peripheral blood ste…
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant [Phase 2]
A Phase 2 trial evaluating the impact of a nutritional program during autologous stem cell transplant was terminated.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lymphoma [Phase 1]
Phase 1 trial evaluating azacitidine in combination with rituximab, vincristine, and cyclophosphamide for refractory lymphoma completed.
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Statin Therapy in Young Adult Survivors of Childhood Cancer [Phase 2]
Phase 2 clinical trial update evaluating statin therapy for cardiovascular risk reduction in young adult survivors of childhood cancer; the …
-
CLINICAL_TRIALS trial_result · 2016-10-13Clinical Trial Update: A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial of Brentuximab Vedotin in relapsed or refractory non-Hodgkin lymphoma has completed and results have been posted. The study …
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: A Study of TRU-016 in Combination With Rituximab and Bendamustine in Subjects With Relapsed Indolent Lymphoma [Phase 1]
Phase 1 study evaluating TRU-016 in combination with Rituximab and Bendamustine in relapsed indolent B-cell lymphoma; results posted in 2016…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial update for SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203) [Phase 2, Phase 3]
A Phase 2/3 trial comparing Rituximab plus standard CHOP versus Rituximab plus bi-weekly CHOP in untreated stage III/IV low-grade B-cell lym…
-
CLINICAL_TRIALS trial_result · 2016-09-12Clinical Trial Update: Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit [Phase 1]
This update reports the completion of a Phase 1 trial evaluating a single treatment with FT1050, an ex-vivo modulated umbilical cord blood u…
-
CLINICAL_TRIALS trial_result · 2016-08-29Clinical Trial Update: A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a [Phase 3]
Phase 3 trial comparing subcutaneous versus intravenous Rituxan in CD20+ diffuse large B-cell lymphoma and CD20+ follicular non-Hodgkin's ly…
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Umbilical Cord Blood Transplant for Hematological Malignancies [Phase 1]
Phase 1 clinical trial evaluating umbilical cord blood transplantation for hematologic malignancies has completed enrollment and reporting.
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant [Phase 1]
This Phase 1 trial update reports on the safety and preliminary efficacy of Bexxar (tositumomab) in patients with relapsed or residual B-cel…
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma [Phase 1, Phase 2]
An early-phase study of flavopiridol (alvocidib) in patients with relapsed or refractory lymphoma or multiple myeloma; the Phase 1/2 trial w…